Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer NCT00063999 Recurrent Uteri...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IVA Uteri...
Stage IVB Uteri...
Carboplatin
Cisplatin
Doxorubicin Hyd...
Filgrastim
Laboratory Biom...
Paclitaxel
Pegfilgrastim
Quality-of-Life...
18 Years - GOG Foundation View Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer NCT01935934 Endometrial Ade...
Endometrial Cle...
Endometrial Mix...
Endometrial Ser...
Metastatic Endo...
Recurrent Uteri...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Uterine Corpus ...
Cabozantinib S-...
Laboratory Biom...
Pharmacological...
18 Years - National Cancer Institute (NCI) View Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer NCT01005329 Endometrial Ade...
Endometrial Ade...
Endometrial Cle...
Endometrial Ser...
Stage IA Uterin...
Stage IB Uterin...
Stage II Uterin...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IVA Uteri...
Stage IVB Uteri...
Bevacizumab
Carboplatin
Cisplatin
Intensity-Modul...
Paclitaxel
18 Years - National Cancer Institute (NCI) View Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer NCT01440998 Endometrial Ade...
Endometrial Cle...
Endometrial Muc...
Endometrial Ser...
Endometrial Squ...
Endometrial Tra...
Endometrial Und...
Endometrioid Ad...
Recurrent Uteri...
Stage III Uteri...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Carboplatin
Dasatinib
Laboratory Biom...
Paclitaxel
18 Years - National Cancer Institute (NCI) View Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer NCT02684227 Recurrent Endom...
Recurrent Uteri...
Stage III Uteri...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Carboplatin
Enzalutamide
Laboratory Biom...
Paclitaxel
Pharmacological...
18 Years - M.D. Anderson Cancer Center View Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer NCT03902379 Endometrial Car...
Stage 0 Fallopi...
Stage I Fallopi...
Stage I Ovarian...
Stage IA Fallop...
Stage IA Ovaria...
Stage IB Fallop...
Stage IB Ovaria...
Stage IC Fallop...
Stage IC Ovaria...
Stage II Cervic...
Stage II Fallop...
Stage II Ovaria...
Stage II Uterin...
Stage IIA Cervi...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA1 Cerv...
Stage IIA2 Cerv...
Stage IIB Cervi...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage III Cervi...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage III Uteri...
Stage IIIA Cerv...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIB Cerv...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Cervic...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVA Uteri...
Stage IVB Cervi...
Stage IVB Uteri...
Uterine Carcino...
Uterine Corpus ...
Internet-Based ...
Quality-of-Life...
Questionnaire A...
Survey Administ...
18 Years - Rutgers, The State University of New Jersey View Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer NCT00478426 Endometrial Ade...
Endometrial End...
Endometrial Ser...
Recurrent Uteri...
Stage IVA Uteri...
Stage IVB Uteri...
Uterine Carcino...
Uterine Corpus ...
Sunitinib Malat...
18 Years - National Cancer Institute (NCI) View Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer NCT03902379 Endometrial Car...
Stage 0 Fallopi...
Stage I Fallopi...
Stage I Ovarian...
Stage IA Fallop...
Stage IA Ovaria...
Stage IB Fallop...
Stage IB Ovaria...
Stage IC Fallop...
Stage IC Ovaria...
Stage II Cervic...
Stage II Fallop...
Stage II Ovaria...
Stage II Uterin...
Stage IIA Cervi...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA1 Cerv...
Stage IIA2 Cerv...
Stage IIB Cervi...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage III Cervi...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage III Uteri...
Stage IIIA Cerv...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIB Cerv...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Cervic...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVA Uteri...
Stage IVB Cervi...
Stage IVB Uteri...
Uterine Carcino...
Uterine Corpus ...
Internet-Based ...
Quality-of-Life...
Questionnaire A...
Survey Administ...
18 Years - Rutgers, The State University of New Jersey View Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery NCT02315469 Endometrial Ser...
Fallopian Tube ...
Malignant Femal...
Ovarian Carcino...
Primary Periton...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IVA Uteri...
Stage IVB Uteri...
Comprehensive G...
Questionnaire A...
70 Years - NRG Oncology View Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery NCT02315469 Endometrial Ser...
Fallopian Tube ...
Malignant Femal...
Ovarian Carcino...
Primary Periton...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IVA Uteri...
Stage IVB Uteri...
Comprehensive G...
Questionnaire A...
70 Years - NRG Oncology View Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer NCT01935934 Endometrial Ade...
Endometrial Cle...
Endometrial Mix...
Endometrial Ser...
Metastatic Endo...
Recurrent Uteri...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Uterine Corpus ...
Cabozantinib S-...
Laboratory Biom...
Pharmacological...
18 Years - National Cancer Institute (NCI) View Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer NCT01005329 Endometrial Ade...
Endometrial Ade...
Endometrial Cle...
Endometrial Ser...
Stage IA Uterin...
Stage IB Uterin...
Stage II Uterin...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IVA Uteri...
Stage IVB Uteri...
Bevacizumab
Carboplatin
Cisplatin
Intensity-Modul...
Paclitaxel
18 Years - National Cancer Institute (NCI) View Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer NCT01005329 Endometrial Ade...
Endometrial Ade...
Endometrial Cle...
Endometrial Ser...
Stage IA Uterin...
Stage IB Uterin...
Stage II Uterin...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IVA Uteri...
Stage IVB Uteri...
Bevacizumab
Carboplatin
Cisplatin
Intensity-Modul...
Paclitaxel
18 Years - National Cancer Institute (NCI) View Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer NCT00942357 Endometrial Cle...
Endometrial Ser...
Stage IA Uterin...
Stage IB Uterin...
Stage II Uterin...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IVA Uteri...
Carboplatin
Cisplatin
Internal Radiat...
Paclitaxel
Quality-of-Life...
Radiation Thera...
18 Years - GOG Foundation View Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer NCT01970722 FIGO Stage IVA ...
FIGO Stage IVB ...
Platinum-Resist...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Recurrent Uteri...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage III Uteri...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Carboplatin
Cisplatin
Gemcitabine Hyd...
Laboratory Biom...
Paclitaxel
Pegylated Lipos...
Quality-of-Life...
Therapeutic Con...
18 Years - City of Hope Medical Center View Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer NCT00977574 Endometrial Ade...
Endometrial Ade...
Endometrial Cle...
Endometrial Ser...
Recurrent Uteri...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IVA Uteri...
Stage IVB Uteri...
Bevacizumab
Carboplatin
Ixabepilone
Laboratory Biom...
Paclitaxel
Temsirolimus
18 Years - National Cancer Institute (NCI) View Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer NCT01970722 FIGO Stage IVA ...
FIGO Stage IVB ...
Platinum-Resist...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Recurrent Uteri...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage III Uteri...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Carboplatin
Cisplatin
Gemcitabine Hyd...
Laboratory Biom...
Paclitaxel
Pegylated Lipos...
Quality-of-Life...
Therapeutic Con...
18 Years - City of Hope Medical Center View